News Daily News Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI L.A. McKeown February 09, 2016
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Daily News Según un Análisis los Beneficios Hemorrágico de la Bivalirudina Disminuyen a medida que Avanza la PCI Todd Neale December 14, 2015
News Daily News Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines Yael L. Maxwell December 14, 2015
News Daily News Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows Todd Neale December 14, 2015
News Conference News AHA 2015 Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding Todd Neale November 10, 2015
News Conference News TCT 2015 Experts Debate Optimal Pharmacologic Approach for STEMI Patients October 11, 2015
News Daily News Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent Yael L. Maxwell October 09, 2015
News Daily News ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further Yael L. Maxwell October 09, 2015
News Daily News No Interplay Between Access Site, Cangrelor Effects in PCI Patients Caitlin E. Cox October 06, 2015
News Daily News No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI Caitlin E. Cox October 06, 2015
News Daily News Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy L.A. McKeown September 21, 2015
News Daily News Bivalirudina Upstream en Pacientes SCASEST resulta Óptima Con Estrategia Invasiva Programada L.A. McKeown September 21, 2015
News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Conference News ESC 2015 Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI Yael L. Maxwell August 31, 2015
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
News Daily News Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT May 14, 2015